Cargando…

Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews

Current methods to assess asthma and guide inhaled corticosteroid (ICS) dose titration mainly centre on patient-reported symptoms and lung function assessments. However, these methods correlate only weakly with airway inflammation making them unreliable predictors of future exacerbations and ICS req...

Descripción completa

Detalles Bibliográficos
Autores principales: Santillo, Marta, Ainsworth, Ben, Van Velthoven, Michelle Helena, Yardley, Lucy, Thomas, Mike, Wang, Kay, Tonkin-Crine, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938430/
https://www.ncbi.nlm.nih.gov/pubmed/35314710
http://dx.doi.org/10.1038/s41533-022-00272-0
_version_ 1784672551574700032
author Santillo, Marta
Ainsworth, Ben
Van Velthoven, Michelle Helena
Yardley, Lucy
Thomas, Mike
Wang, Kay
Tonkin-Crine, Sarah
author_facet Santillo, Marta
Ainsworth, Ben
Van Velthoven, Michelle Helena
Yardley, Lucy
Thomas, Mike
Wang, Kay
Tonkin-Crine, Sarah
author_sort Santillo, Marta
collection PubMed
description Current methods to assess asthma and guide inhaled corticosteroid (ICS) dose titration mainly centre on patient-reported symptoms and lung function assessments. However, these methods correlate only weakly with airway inflammation making them unreliable predictors of future exacerbations and ICS requirement. Fractional Exhaled Nitric Oxide (FeNO) is a simple non-invasive objective measure of airways inflammation used predominantly in specialist clinics. Previous qualitative studies have mainly focused on the acceptability of FeNO in secondary care and there is limited insight to support clinicians and patients using FeNO in primary care asthma reviews. This study aimed to explore adult patient with asthma and primary care health care professional (HCP) views on introducing FeNO as part of routine asthma reviews. Twenty-three health care professionals and 22 patients were interviewed over the phone or online. Both groups reported that current asthma reviews are often seen as tick-box exercises and that introducing the FeNO test would make reviews more tailored to the individual patient, rather than relying on subjective patient reports of asthma control. Adults with asthma also highlighted support more open communication and their understanding of asthma, as they desired to feel more engaged in decisions and conversations about their asthma. HCPs reported valuing patient education and empowerment over a paternalistic approach, when time and resources allow. They also recognised FeNO to provide an objective measure of inflammation that could support them in the education and empowerment of patients. FeNO was seen by both groups as a potentially valuable addition to current asthma reviews mainly led by nurses, both for increasing their understanding of current risk of exacerbation and also to provide more tailored and personalised asthma management to patients. Our findings highlighted the need for open and clear communication about how to interpret FeNO results.
format Online
Article
Text
id pubmed-8938430
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89384302022-04-08 Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews Santillo, Marta Ainsworth, Ben Van Velthoven, Michelle Helena Yardley, Lucy Thomas, Mike Wang, Kay Tonkin-Crine, Sarah NPJ Prim Care Respir Med Article Current methods to assess asthma and guide inhaled corticosteroid (ICS) dose titration mainly centre on patient-reported symptoms and lung function assessments. However, these methods correlate only weakly with airway inflammation making them unreliable predictors of future exacerbations and ICS requirement. Fractional Exhaled Nitric Oxide (FeNO) is a simple non-invasive objective measure of airways inflammation used predominantly in specialist clinics. Previous qualitative studies have mainly focused on the acceptability of FeNO in secondary care and there is limited insight to support clinicians and patients using FeNO in primary care asthma reviews. This study aimed to explore adult patient with asthma and primary care health care professional (HCP) views on introducing FeNO as part of routine asthma reviews. Twenty-three health care professionals and 22 patients were interviewed over the phone or online. Both groups reported that current asthma reviews are often seen as tick-box exercises and that introducing the FeNO test would make reviews more tailored to the individual patient, rather than relying on subjective patient reports of asthma control. Adults with asthma also highlighted support more open communication and their understanding of asthma, as they desired to feel more engaged in decisions and conversations about their asthma. HCPs reported valuing patient education and empowerment over a paternalistic approach, when time and resources allow. They also recognised FeNO to provide an objective measure of inflammation that could support them in the education and empowerment of patients. FeNO was seen by both groups as a potentially valuable addition to current asthma reviews mainly led by nurses, both for increasing their understanding of current risk of exacerbation and also to provide more tailored and personalised asthma management to patients. Our findings highlighted the need for open and clear communication about how to interpret FeNO results. Nature Publishing Group UK 2022-03-21 /pmc/articles/PMC8938430/ /pubmed/35314710 http://dx.doi.org/10.1038/s41533-022-00272-0 Text en © Crown 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Santillo, Marta
Ainsworth, Ben
Van Velthoven, Michelle Helena
Yardley, Lucy
Thomas, Mike
Wang, Kay
Tonkin-Crine, Sarah
Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
title Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
title_full Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
title_fullStr Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
title_full_unstemmed Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
title_short Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
title_sort qualitative study on perceptions of use of fractional exhaled nitric oxide (feno) in asthma reviews
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938430/
https://www.ncbi.nlm.nih.gov/pubmed/35314710
http://dx.doi.org/10.1038/s41533-022-00272-0
work_keys_str_mv AT santillomarta qualitativestudyonperceptionsofuseoffractionalexhalednitricoxidefenoinasthmareviews
AT ainsworthben qualitativestudyonperceptionsofuseoffractionalexhalednitricoxidefenoinasthmareviews
AT vanvelthovenmichellehelena qualitativestudyonperceptionsofuseoffractionalexhalednitricoxidefenoinasthmareviews
AT yardleylucy qualitativestudyonperceptionsofuseoffractionalexhalednitricoxidefenoinasthmareviews
AT thomasmike qualitativestudyonperceptionsofuseoffractionalexhalednitricoxidefenoinasthmareviews
AT wangkay qualitativestudyonperceptionsofuseoffractionalexhalednitricoxidefenoinasthmareviews
AT tonkincrinesarah qualitativestudyonperceptionsofuseoffractionalexhalednitricoxidefenoinasthmareviews